52 POSTER Preclinical development of PTC299: an orally...

52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density

T. Davis, L. Cao, N. Tamilarasu, N. Risher, H. Qi, C. Romfo, J. Bombard, J. Sheedy, M. Weetall, Y. Moon
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)70058-1
File:
PDF, 59 KB
english, 2006
Conversion to is in progress
Conversion to is failed